Mothercare

This function is exclusive for Premium subscribers

  • DATABASE (12)

  • ARTICLES (8)

    • DATABASE (12)
    • ARTICLES (8)

TurtleTree Labs will license its technology for creating natural ingredients found in human milk to dairy and infant formula companies to produce full-composition liquid milk.

AI-powered WOOM fertility app has +1m users, helped 60,000+ women conceive while providing medical advice and a vast social network; set for rapid expansion.

Chinese medtech taps billion-dollar global fetal monitoring market with Modoo Pro – the world’s smallest passive fetal heart monitor. 

A mobile platform that combines online medical counseling with offline clinical services to address mother-and-child healthcare concerns.

China’s largest online parenting community Babytree is the first to identify the core needs of (new) mothers: gain parenting knowledge, socialize, record and share, shopping.

E-commerce giants Moxy and Bilna have joined forces to transform into Orami, aiming to be the top online shopping destination for Southeast Asian women.

Established in 2014 as a private equity firm, Hawthorn Investment engages in equity investment, M&As and capital management. It invests mainly in the emerging automotive technology, healthcare, high-end manufacturing, culture and sports sectors.

Established in Shenzhen in 2007, Share Capital has invested in over 100 companies. Some of its portfolio companies – e.g., NavInfo, Perfect World and BGI – have gone public. Its investment team of nearly 50 members manages more than RMB 6 billion worth of assets. Share Capital has set up a healthcare fund of RMB 1.5 billion and invested in over 70 health-related projects.

Established as an asset management company in 2017, Chasestone Capital has launched major funds in real estate, private equity, consumer finance and securities investment. The company completed its Series A funding round in September 2017 with backing from well-known investors such as Orient Capital, SBCVC, Cowin Capital, Bridge Capital, GIG and Tsing Ventures.

The Alexa Fund provides up to $200 million in venture capital funding to fuel voice technology innovation. It is focused on how voice technology can improve customers’ lives, from early-stage pre-revenue companies to established brands. Areas of particular interest include: hardware products that would benefit from the Alexa Voice Service; skills that deliver new abilities to Alexa-enabled devices through the Alexa Skills Kit; and new contributions to the science behind voice technology, including text to speech, natural language understanding, automatic speech recognition, artificial intelligence and hardware component design.

Founded in Beijing in May 2015, Chunxiao Capital mainly invests in angel/seed to Series B funding rounds. With staff of 22, the VC has invested in over 50 companies by March 2019. Investments include technology innovations in fintech, big data and AI. Other investment sectors involve corporate services, Industry 4.0, B2B and SaaS for industrial enterprises and consumer-oriented businesses like retail, sports, maternal and infant care.In May 2019, the Asset Management Association of China revoked Chunxiao's private equity certification due to links with five online P2P lending firms facing default problems.

Founded in Beijing in 2015, Frees Fund is an asset management company with a portfolio valued at RMB 3.6bn. Frees primarily invests in early-stage startups in diverse sectors including fintech, education, healthcare, entertainment, hardware, intelligent manufacturing and SaaS. The VC is incorporated as Shanghai Ziyou Investment Management Co Ltd.

Your payment was not successful.

Please make sure you have entered your payment details correctly. Or try again in a few moments.

small logo

The discount code you entered is invalid

Please make sure you have entered your discount code correctly. Or try again in a few moments.

Download successful.

Your sample has been sent. Please check your email.

By accessing and using www.compasslist.com and all pages within the domain (the “Website”), You accept and agree to have read, understood, accepted and agreed to be bound by the Terms of Use and Privacy Policy in full. If you disagree with all or any part of these Terms of Use and Privacy Policy, please do not use or continue any further use of this website. You acknowledge that you are aware that this Website contains an archive of existing content as at 31 December 2021 and is not being actively managed. We are under no obligation to update the content on this Website and, accordingly, no new content or articles will be posted to the Website after 31 December 2021.